Evidence map›Paper›PMID 36441294›Full record

ArticleActa parasitologica2023

Trypanosoma Congolense Resistant to Trypanocidal Drugs Homidium and Diminazene and their Molecular Characterization in Lambwe, Kenya.

Ivy Okello, Eliakunda Mafie, Jahashi Nzalawahe, Gillian Eastwood, Leonard E G Mboera, Jean Nepomuscene Hakizimana, Kennedy Ogola

Abstract read
PubMed Publisher
In one paragraph

Article in Acta parasitologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.International journal for parasitology. Drugs and drug resistance · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Ivy OkelloAfrica Centre of Excellence for Infectious Diseases of Humans and Animals in East and Southern Africa, SACIDS Foundation for One Health, P.O. Box 3297, Morogoro, Tanzania. ivyokello4@gmail.com.ORCID http://orcid.org/0000-0002-2094-5621
Eliakunda MafieDepartment of Veterinary Microbiology, Parasitology and Biotechnology, Sokoine University of Agriculture, Chuo Kikuu, P.O. BOX 3019, Morogoro, Tanzania.
Jahashi NzalawaheDepartment of Veterinary Microbiology, Parasitology and Biotechnology, Sokoine University of Agriculture, Chuo Kikuu, P.O. BOX 3019, Morogoro, Tanzania.
Gillian EastwoodDepartment of Entomology, College of Agriculture & Life Sciences, Virginia Polytechnic Institute & State University, Blacksburg, VA, USA.
Leonard E G MboeraAfrica Centre of Excellence for Infectious Diseases of Humans and Animals in East and Southern Africa, SACIDS Foundation for One Health, P.O. Box 3297, Morogoro, Tanzania.
Jean Nepomuscene HakizimanaAfrica Centre of Excellence for Infectious Diseases of Humans and Animals in East and Southern Africa, SACIDS Foundation for One Health, P.O. Box 3297, Morogoro, Tanzania.
Kennedy OgolaPharmacology & Molecular Laboratory, Agricultural & Livestock Research Organization, Biotechnology Research Institute, P. O. Box 362, Kikuyu, Kenya.
Southern African Centre for Infectious Disease Surveillance · TZSokoine University of Agriculture · TZKenya Agricultural and Livestock Research Organization · KEVirginia Tech · US

Funding

Partnership for Skills in Applied Sciences, Engineering and Technology-Regional Scholarship Innovative Fund PhD Scholarship
6 · The paper itself

Abstract

purposeAfrican animal trypanosomiasis (AAT) is a disease affecting livestock in sub-Saharan Africa. The use of trypanocidal agents is common practice to control AAT. This study aimed to identify drug-resistant Trypanosoma congolense in Lambwe, Kenya, and assess if molecular test backed with mice tests is reliable in detecting drug sensitivity.

methodsBlood samples were collected from cattle, in Lambwe, subjected to buffy coat extraction and Trypanosoma spp. detected under a microscope. Field and archived isolates were subjected to molecular characterization. Species-specific T. congolense and TcoAde2 genes were amplified using PCR to detect polymorphisms. Phylogenetic analysis were performed. Four T. congolense isolates were evaluated individually in 24 test mice per isolate. Test mice were then grouped (n=6) per treatement with diminazene, homidium, isometamidium, and controls. Mice were subsequently assessed for packed cell volume (PCV) and relapses using microscopy.

resultsOf 454 samples, microscopy detected 11 T. congolense spp, eight had TcoAde2 gene, six showed polymorphisms in molecular assay. Phylogenetic analysis grouped isolates into five. Two archived isolates were homidium resistant, one was also diminazene resistant in mice. Two additional isolates were sensitive to all the drugs. Interestingly, one sensitive isolate lacked polymorphisms, while the second lacked TcoAde2, indicating the gene is not involved in drug sensitivity. Decline in PCV was pronounced in relapsed isolates.

conclusionT. congolense associated with homidium and diminazene resistance exist in Lambwe. The impact can be their spread and AAT increase. Polymorphisms are present in Lambwe strains. TcoAde2 is unlikely involved in drug sensitivity. Molecular combined with mice tests is reliable drug sensitivity test and can be applied to other genes. Decline in PCV in infected-treated host could suggest drug resistance.

Indexed as

Trypanocidal AgentsTrypanosoma congolenseTrypanosomiasis, AfricanAnimalsCattleDiminazeneEthidiumKenyaMicePhylogenyDiminazeneEthidiumTrypanocidal AgentsDiminazeneDrug resistanceHomidiumIsometamidiumKenyaTrypanosoma congolense

Identifiers

PMID36441294
OpenAlexW4310197301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.